Patient enrolment concludes in Senhwa’s Phase Ib trial of pidnarulex
The study’s next steps are data review, database lock, statistical analysis, and a clinical study report in 2027.
Analysis
View MoreAPIs to the rescue?
Oral bioavailability remains one of the biggest challenges in drug development, particularly for small-molecule APIs with poor solubility or permeability. Liam Critchley explores how pharmaceutical companies are using integrated formulation...
AI now: What QbD and PAT missed
Cool heads, smart chains
Sustainability vs suitability
Integrating sustainability compliance